کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
4225002 1609748 2015 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication
ترجمه فارسی عنوان
تمایز بین متاستازهای پانکراس از کارسینوم سلولهای کلیوی و تومور نوروندوکرین هیپورواستروکولیک: استفاده از درصد تخلیه نسبی و معاینه بالینی آن
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی رادیولوژی و تصویربرداری
چکیده انگلیسی

PurposeTo compare computed tomography (CT) findings in patients with pancreatic metastasis from renal cell carcinoma (pRCC) and patients with hypervascular pancreatic neuroendocrine tumour (pNET) with a focus on the relative percentage washout (RPW).MethodsWe evaluated 16 patients with 37 pRCCs and 28 patients with 31 hypervascular pNETs using a protocol consisting of arterial and portal phase CT. Imaging findings were analyzed for comparison between the two groups. The RPW of each tumour using biphasic CT was obtained by two observers for evaluation of diagnostic performance. Interobserver agreement of each value and optimal cut-off level of RPW for discrimination between groups were evaluated.ResultsTumour multiplicity showed significant difference in both groups. The mean RPW of the pRCC group (observer 1, 27.0%; observer 2, 29.4%) was significantly higher than that of the pNET group (observer 1, 0.5%; observer 2, 3.2%) (p < 0.001 for each observer). Interobserver agreement for both attenuation values and RPWs was excellent. A RPW value of 19% was selected as the optimal cut-off for pRCC determination, and showed good performance (accuracy 83.8%, sensitivity 83.8%, and specificity 83.9%).ConclusionWith multiplicity, RPW of the tumour on CT could be helpful for differentiating pRCCs from hypervascular pNETs.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Radiology - Volume 84, Issue 11, November 2015, Pages 2089–2096
نویسندگان
, , , , , , ,